Cited by 1,828Substance Abuse Treatment and OutcomesAlcohol Consumption and Health EffectsAlcoholism and Thiamine Deficiency

The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.

Naltrexone in the Treatment of Alcohol Dependence

Volpicelli, Joseph R.·1992·Archives of General Psychiatry

DOI 10.1001/archpsyc.1992.01820110040006

Open this paper in CoChat — free account

Abstract

Seventy male alcohol-dependent patients participated in a 12-week, double-blind, placebo-controlled trial of naltrexone hydrochloride (50 mg/d) as an adjunct to treatment following alcohol detoxification. Subjects taking naltrexone reported significantly less alcohol craving and days in which any alcohol was consumed. During the 12-week study, only 23% of the naltrexone-treated subjects met the criteria for a relapse, whereas 54.3% of the placebo-treated subjects relapsed. The primary effect of naltrexone was seen in patients who drank any alcohol while attending outpatient treatment. Nineteen (95%) of the 20 placebo-treated patients relapsed after they sampled alcohol, while only eight (50%) of 16 naltrexone-treated patients exposed to alcohol met relapse criteria. Naltrexone was not associated with mood changes or other psychiatric symptoms. Significant side effects (nausea) occurred in two naltrexone-treated subjects, and one naltrexone-treated subject complained of increased pain from arthritis. These results suggest that naltrexone may be a safe and effective adjunct to treatment in alcohol-dependent subjects, particularly in preventing alcohol relapse.

Integrity signals

Registry

Crossref · 10.1001/archpsyc.1992.01820110040006

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The Hopkins Symptom Checklist (HSCL): A self-report symptom inventory
Derogatis, L. R., Lipman, R. S., Rickels, K., Uhlenhuth, E. H., & Covi, L. (1974) · Behavioral Science · doi:10.1002/bs.3830190102 · Cited by 4,604
Survival Analysis
Miller, R. G. (1981) · Cited by 3,336
Disulfiram treatment of alcoholism. A Veterans Administration cooperative study
Fuller, R. K. (1986) · JAMA · doi:10.1001/jama.256.11.1449 · Cited by 541
Alteration of ethanol self-administration by naltrexone
Altshuler, H. L., Phillips, P. E., & Feinhandler, D. A. (1980) · Life Sciences · doi:10.1016/0024-3205(80)90257-x · Cited by 397
The Effectiveness of Alcoholism Treatment
Miller, W. R., & Hester, R. K. (1986) · Springer eBooks · doi:10.1007/978-1-4613-2191-0_7 · Cited by 276
The serotonin uptake inhibitor citalopram attenuates ethanol intake
Naranjo, C. A., Sellers, E. M., Sullivan, J. T., Woodley-Remus, D., Kadlec, K. E., & Sykora, K. (1987) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1987.27 · Cited by 236
Naltrexone blocks the post-shock increase of ethanol consumption
Volpicelli, J. R., Davis, M. A., & Olgin, J. E. (1986) · Life Sciences · doi:10.1016/0024-3205(86)90601-6 · Cited by 187
Self-citation
Antagonism by naltrexone of voluntary alcohol selection in the chronically drinking macaque monkey
Myers, R. D., Borg, S., & Mossberg, R. (1986) · Alcohol · doi:10.1016/0741-8329(86)90058-3 · Cited by 167
Lithium Treatment of Depressed and Nondepressed Alcoholics
Dorus, W. (1989) · JAMA · doi:10.1001/jama.1989.03430120100029 · Cited by 164
Oral ethanol self-administration in the rat: Effect of naloxone
Samson, H. H., & Doyle, T. F. (1985) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(85)90491-5 · Cited by 162

Show all 23 references

Sorted by citations

Items 601–700 of 1,004

Pharmacotherapy for Alcohol Dependence: Anticraving Medications for Relapse Prevention
Jung, Y., & Namkoong, K. (2006) · Yonsei Medical Journal · doi:10.3349/ymj.2006.47.2.167 · Cited by 49
Mu (μ) Opioid Receptor Regulation of Ethanol-Induced Dopamine Response in the Ventral Striatum: Evidence of Genotype Specific Sexual Dimorphic Epistasis
Job, M. O., Tang, A., Hall, F. S., Sora, I., Uhl, G. R., Bergeson, S. E., & Gonzales, R. A. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.11.016 · Cited by 51
Supplier-dependent differences in intermittent voluntary alcohol intake and response to naltrexone in Wistar rats
Momeni, S., Segerström, L., & Roman, E. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00424 · Cited by 36
Dopamine and opioid systems adaptation in alcoholism revisited: Convergent evidence from positron emission tomography and postmortem studies
Hansson, A. C., Gründer, G., Hirth, N., Noori, H. R., Spanagel, R., & Sommer, W. H. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.09.010 · Cited by 55
Genetically Selected Alcohol Preferring Rats to Model Human Alcoholism
Ciccocioppo, R. (2012) · Current topics in behavioral neurosciences · doi:10.1007/7854_2012_199 · Cited by 49
Predictors of Retention in Naltrexone Maintenance for Opioid Dependence: Analysis of a Stage I Trial
Sullivan, M. A., Rothenberg, J. L., Vosburg, S. K., Church, S. H., Feldman, S. J., Epstein, E. M., Kleber, H. D., & Nunes, E. V. (2006) · American Journal on Addictions · doi:10.1080/10550490500528464 · Cited by 48
Toward a definition of a valid model of alcoholism: Multiple animal models for multiple diseases
McMillen, B. A. (1997) · Alcohol · doi:10.1016/s0741-8329(97)90012-4 · Cited by 49
Low-Dose Topiramate in Alcohol Dependence
Martinotti, G., Nicola, M. D., Vita, O. D., Hatzigiakoumis, D. S., Guglielmo, R., Santucci, B. A., Aliotta, F., Romanelli, R., Verrastro, V., Petruccelli, F., et al. (2014) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000228 · Cited by 48
Effects of melanocortin receptor ligands on ethanol intake and opioid peptide levels in alcohol-preferring AA rats
Ploj, K., Roman, E., Kask, A., Hyytiä, P., Schiöth, H. B., Wikberg, J. E. S., & Nylander, I. (2002) · Brain Research Bulletin · doi:10.1016/s0361-9230(02)00844-4 · Cited by 48
New Insights into the Efficacy of Naltrexone Based on Trajectory-Based Reanalyses of Two Negative Clinical Trials
Gueorguieva, R. V., Wu, R., Pittman, B. P., Cramer, J. A., Rosenheck, R. A., O’Malley, S. S., & Krystal, J. H. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.09.038 · Cited by 47
Bremazocine reduces unrestricted free-choice ethanol self-administration in rats without affecting sucrose preference
Nestby, P., Schoffelmeer, A. N. M., Homberg, J. R., Wardeh, G., Vries, T. J. D., Mulder, A. H., & Vanderschuren, L. J. M. J. (1999) · Psychopharmacology · doi:10.1007/s002130050894 · Cited by 48
Central Opioid Receptors Differentially Regulate the Nalmefene-Induced Suppression of Ethanol- and Saccharin-Reinforced Behaviors in Alcohol-Preferring (P) Rats
June, H. L., Cummings, R., Eiler, W. J. A., Foster, K. L., McKay, P. F., Seyoum, R., García, M., McCane, S., Grey, C., Hawkins, S. E., et al. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300338 · Cited by 48
A Small Dose of Morphine Leads Rats to Drink More Alcohol and Achieve Higher Blood Alcohol Concentrations
Hubbell, C. L., Mankes, R. F., & Reid, L. D. (1993) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1993.tb05661.x · Cited by 48
INTERACTIONS BETWEEN CANNABINOID AND OPIOID RECEPTOR SYSTEMS IN THE MEDIATION OF ETHANOL EFFECTS
Manzanares, J., Ortiz, S., Oliva, J. M., Pérez-Rial, S., & Palomo, T. (2004) · Alcohol and Alcoholism · doi:10.1093/alcalc/agh112 · Cited by 48
A Risk-Benefit Assessment of Naltrexone in the Treatment of Alcohol Dependence
Berg, B. J., Pettinati, H. M., & Volpicelli, J. R. (1996) · Drug Safety · doi:10.2165/00002018-199615040-00005 · Cited by 48
Self-citation
Enhanced activity of the brain β-endorphin system by free-choice ethanol drinking in C57BL/6 but not DBA/2 mice
de Waele, J., & Gianoulakis, C. (1994) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)90064-7 · Cited by 47
Recent developments in the pharmacotherapy of substance abuse.
O'Brien, C. P. (1996) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.64.4.677 · Cited by 49
Endogenous Opioid Signaling in the Medial Prefrontal Cortex is Required for the Expression of Hunger-Induced Impulsive Action
Selleck, R. A., Lake, C., Estrada, V., Riederer, J., Andrzejewski, M. E., Sadeghian, K., & Baldo, B. A. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.97 · Cited by 47
Craving e dependência química: conceito, avaliação e tratamento
Araújo, R. B., Oliveira, M. D. S., Pedroso, R. S., Miguel, A. C., & de Castro, M. D. G. T. (2008) · Jornal Brasileiro de Psiquiatria · doi:10.1590/s0047-20852008000100011 · Cited by 62
Varenicline, low dose naltrexone, and their combination for heavy-drinking smokers: human laboratory findings
Ray, L. A., Courtney, K. E., Ghahremani, D. G., Miotto, K. A., Brody, A. L., & London, E. D. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3519-0 · Cited by 46
The safety of pharmacologic treatment for pediatric obesity
Chao, A. M., Wadden, T. A., & Berkowitz, R. I. (2018) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2018.1437143 · Cited by 49
Modulation of Volitional Ethanol Intake in the Rat by Central delta-Opioid Receptors
Franck, J., Lindholm, S., & Raaschou, P. (1998) · Alcoholism Clinical and Experimental Research · doi:10.1097/00000374-199809000-00001 · Cited by 47
Suppression of Alcohol Preference in High Alcohol Drinking Rats
Myers, R. D., & Lankford, M. F. (1996) · Neuropsychopharmacology · doi:10.1016/0893-133x(95)00081-n · Cited by 47
New Developments in the Pharmacotherapy of Alcohol Dependence
Myrick, H., Brady, K. T., & Malcolm, R. J. (2001) · American Journal on Addictions · doi:10.1080/10550490150504092 · Cited by 47
Young People in Alcoholics Anonymous: The Role of Spiritual Orientation and AA Member Affiliation
Galanter, M. S., Dermatis, H., & Santucci, C. (2012) · Journal of Addictive Diseases · doi:10.1080/10550887.2012.665693 · Cited by 46
Reduction of alcohol drinking and upregulation of opioid receptors by oral naltrexone in AA rats
Parkes, H., & Sinclair, J. D. (2000) · Alcohol · doi:10.1016/s0741-8329(00)00091-4 · Cited by 46
Oral Ethanol‐Reinforced Responding in Rhesus Monkeys: Effects of Opioid Antagonists Selective for the μ‐,κ‐, or δ‐Receptor
Williams, K. L., & Woods, J. H. (1998) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1998.tb03960.x · Cited by 46
Reward, Relief and Habit Drinking: Initial Validation of a Brief Assessment Tool
Grodin, E. N., Bujarski, S., Venegas, A., Baskerville, W., Nieto, S. J., Jentsch, D., & Ray, L. A. (2019) · Alcohol and Alcoholism · doi:10.1093/alcalc/agz075 · Cited by 48
Enhancement of transdermal delivery of 6-β-naltrexol via a codrug linked to hydroxybupropion
Kiptoo, P. K., Hamad, M. O., Crooks, P. A., & Stinchcomb, A. L. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.04.003 · Cited by 46
Acamprosate in the treatment of alcohol dependence
Mason, B. J. (2005) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.6.12.2103 · Cited by 46
Daidzin Decreases Ethanol Consumption in Rats
Heyman, G. M., Keung, W., & Vallée, B. L. (1996) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1996.tb01950.x · Cited by 46
Effects of naltrexone on cue-elicited craving for alcohol and cocaine
Modesto‐Lowe, V., Burleson, J. A., Hersh, D., Bauer, L. O., & Kranzler, H. R. (1997) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(97)00134-8 · Cited by 46
Pharmacokinetics, safety, and tolerability of a depot formulation of naltrexone in alcoholics: an open-label trial
Galloway, G. P., Koch, M., Cello, R., & Smith, D. E. (2005) · BMC Psychiatry · doi:10.1186/1471-244x-5-18 · Cited by 46
Non-specific effect of naltrexone on ethanol consumption in social drinkers
de Wit, H., Svenson, J., & York, A. (1999) · Psychopharmacology · doi:10.1007/s002130051085 · Cited by 46
[3H]Ethylketocyclazocine Binding to Brain Opioid Receptor Subtypes in Alcohol-Preferring AA and Alcohol-Avoiding ANA Rats
Soini, S. L., Honkanen, A., Hyytiä, P., & Korpi, E. R. (1999) · Alcohol · doi:10.1016/s0741-8329(98)00064-0 · Cited by 46
Poorer Drinking Outcomes with Citalopram Treatment for Alcohol Dependence: A Randomized, Double‐Blind, Placebo‐Controlled Trial
Charney, D. A., Heath, L. M., Zikos, E., Palacios‐Boix, J., & Gill, K. J. (2015) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.12802 · Cited by 45
Effects of naltrexone and ethanol on auditory event-related brain potentials
Jääskeläinen, I. P., Hirvonen, J., Kujala, T., Alho, K., Eriksson, C. J. P., Lehtokoski, A., Pekkonen, E., Sinclair, J. D., Yabe, H., Näätänen, R., et al. (1998) · Alcohol · doi:10.1016/s0741-8329(97)00104-3 · Cited by 45
Could a common biochemical mechanism underlie addictions?
Betz, C., Mihalic, D., Pinto, M. E., & Raffa, R. B. (2000) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1046/j.1365-2710.2000.00260.x · Cited by 44
A Novel Delta Opioid Receptor Antagonist, SoRI-9409, Produces a Selective and Long-Lasting Decrease in Ethanol Consumption in Heavy-Drinking Rats
Nielsen, C. K., Simms, J. A., Pierson, H. B., Li, R., Saini, S. K., Ananthan, S., & Bartlett, S. E. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.07.018 · Cited by 47
Eating Disorders and Alcohol Use Disorders
Grilo, C. M., Sinha, R., & O’Malley, S. S. (2002) · Europe PMC (PubMed Central) · Cited by 45
Naltrexone Decreases Heavy Drinking Rates in Smoking Cessation Treatment: An Exploratory Study
King, A. C., Cao, D., Vanier, C., & Wilcox, T. (2009) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2009.00925.x · Cited by 45
Dose-dependent reduction of hazardous alcohol use in a placebo-controlled trial of naltrexone for smoking cessation
O’Malley, S. S., Krishnan‐Sarin, S., McKee, S. A., Leeman, R. F., Cooney, N. L., Meandzija, B., Wu, R., & Makuch, R. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s146114570800936x · Cited by 45
The Efficacy of Treatments in Reducing Alcohol Consumption: A Meta-Analysis
Agosti, V. (1995) · International Journal of the Addictions · doi:10.3109/10826089509055828 · Cited by 45
Feasibility of multidimensional substance abuse treatment matching: automating the ASAM Patient Placement Criteria
Turner, W. M., Turner, K. H., Reif, S., Gutowski, W. E., & Gastfriend, D. R. (1999) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(98)00178-1 · Cited by 45
Schizophrenia: Improving Outcome
Bustillo, J., Lauriello, J., & Keith, S. J. (1999) · Harvard Review of Psychiatry · doi:10.3109/10673229909000335 · Cited by 45
Naltrexone and Brief Counseling to Reduce Heavy Drinking
Bohn, M. J., Kranzler, H. R., Beazoglou, D., & Staehler, B. A. (1994) · American Journal on Addictions · doi:10.1111/j.1521-0391.1994.tb00375.x · Cited by 45
NIAAA: advancing alcohol research for 40 years.
Warren, K. R., & Hewitt, B. G. (2010) · Europe PMC (PubMed Central) · Cited by 44
Reduction of excessive alcohol drinking by a novel GABAB receptor positive allosteric modulator ADX71441 in mice
Hwa, L. S., Kalinichev, M., Haddouk, H., Poli, S. M., & Miczek, K. A. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3245-z · Cited by 44
Naltrexone modifies the palatability of basic tastes and alcohol in outbred male rats
Ferraro, F. M., Hill, K., Kaczmarek, H. J., Coonfield, D. L., & Kiefer, S. W. (2002) · Alcohol · doi:10.1016/s0741-8329(02)00220-3 · Cited by 44
Naltrexone for probationers and parolees
O’Brien, C. P., & Cornish, J. (2006) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2006.06.002 · Cited by 44
Targeted Naltrexone Treatment Moderates the Relations Between Mood and Drinking Behavior Among Problem Drinkers.
Kranzler, H. R., Armeli, S., Feinn, R., & Tennen, H. A. (2004) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.72.2.317 · Cited by 44
Naltrexone: report of lack of hepatotoxicity in acute viral hepatitis, with a review of the literature
Brewer, C. L., & Wong, V. S. (2004) · Addiction Biology · doi:10.1080/13556210410001674130 · Cited by 44
Organizational-Level Predictors of Adoption Across Time: Naltrexone in Private Substance-Use Disorders Treatment Centers
Oser, C. B., & Roman, P. M. (2007) · Journal of Studies on Alcohol and Drugs · doi:10.15288/jsad.2007.68.852 · Cited by 43
Bioinformatics Analyses Reveal Age-Specific Neuroimmune Modulation as a Target for Treatment of High Ethanol Drinking
Agrawal, R. G., Owen, J. A., Levin, P. S., Hewetson, A., Berman, A., Franklin, S. R., Hogue, R. J., Chen, Y., Walz, C., Colvard, B. D., et al. (2013) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.12288 · Cited by 42
The long-lasting effects of JDTic, a kappa opioid receptor antagonist, on the expression of ethanol-seeking behavior and the relapse drinking of female alcohol-preferring (P) rats
Deehan, G. A., McKinzie, D. L., Carroll, F. I., McBride, W. J., & Rodd, Z. A. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2012.03.006 · Cited by 44
Nucleus accumbens dopamine and mu-opioid receptors modulate the reinstatement of food-seeking behavior by food-associated cues
Guy, E. G., Choi, E., & Pratt, W. E. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.01.024 · Cited by 45
Outcome Study of Kleptomania Patients Treated With Naltrexone
Grant, J. E. (2005) · Clinical Neuropharmacology · doi:10.1097/01.wnf.0000150868.06512.0b · Cited by 40
Mμ and D2 Receptor Antisense Oligonucleotides Injected in Nucleus Accumbens Suppress High Alcohol Intake in Genetic Drinking HEP Rats
Myers, R. D., & Robinson, D. E. (1999) · Alcohol · doi:10.1016/s0741-8329(99)00015-4 · Cited by 45
Pharmacological effects of naltrexone and intravenous alcohol on craving for cigarettes among light smokers: a pilot study
Ray, L. A., Miranda, R., Kahler, C. W., Leventhal, A. M., Monti, P. M., Swift, R. M., & Hutchison, K. E. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0794-z · Cited by 43
Effects of naltrexone on cocaine- and sucrose-seeking behaviour in response to associated stimuli in rats
Burattini, C., Burbassi, S., Aicardi, G., & Cervo, L. (2007) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145707007705 · Cited by 43
Preclinical and Clinical Studies on Naltrexone: What Have They Taught Each Other?
Froehlich, J. C., O’Malley, S. S., Hyytiä, P., Davidson, D., & Farren, C. K. (2003) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000057943.57330.ab · Cited by 43
Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence
O’Brien, C. P. (2005) · Current Psychiatry Reports · doi:10.1007/s11920-005-0031-6 · Cited by 43
Naltrexone and the Treatment of Alcohol Dependence.
Volpicelli, J. R., Clay, K. L., Watson, N. T., & Volpicelli‐Daley, L. A. (1994) · PubMed Central · Cited by 43
Self-citation
Conference Summary: Consensus Conference on Alcohol Dependence and the Role of Pharmacotherapy in its Treatment
Chick, J., & Erickson, C. K. (1996) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1996.tb01658.x · Cited by 42
The Effect of Chronic Ethanol Consumption and Withdrawal on μ-Opioid and Dopamine D1 and D2 Receptor Density in Fawn-Hooded Rat Brain
Djouma, E., & Lawrence, A. J. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.035915 · Cited by 43
Opioid antagonists for smoking cessation
David, S. P., Lancaster, T., Stead, L. F., Evins, A. E., & Cahill, K. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003086.pub2 · Cited by 43
Advances in Medications and Tailoring Treatment for Alcohol Use Disorder
Seneviratne, C. (2015) · Alcohol research · doi:10.35946/arcr.v37.1.02 · Cited by 42
Medications for treating alcohol use disorder: A narrative review
Kranzler, H. R., & Hartwell, E. E. (2023) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.15118 · Cited by 50
The µ-Opioid Receptor and Treatment Response to Naltrexone
Thorsell, A. (2013) · Alcohol and Alcoholism · doi:10.1093/alcalc/agt030 · Cited by 43
The association between depression and craving in alcohol dependency is moderated by gender and by alexithymia factors
Luminet, O., Uva, M. C. D. S., Fantini‐Hauwel, C., & de Timary, P. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.02.062 · Cited by 45
The Need for Treatment Responsive Translational Biomarkers in Alcoholism Research
Heilig, M. A., Sommer, W. H., & Spanagel, R. (2015) · Current topics in behavioral neurosciences · doi:10.1007/7854_2015_5006 · Cited by 45
Motivational factors and negative affectivity as predictors of alcohol craving
Pombo›, S., Figueira, M. L., Walter, H., & Lesch, O. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.02.064 · Cited by 42
Anti‐dipsotropic isoflavones: The potential therapeutic agents for alcohol dependence
Keung, W. M. (2003) · Medicinal Research Reviews · doi:10.1002/med.10049 · Cited by 42
Alcoholism Treatment in the United States.
McCaul, M. E., & Furst, J. (1994) · PubMed Central · Cited by 42
Naltrexone long-acting formulation in the treatment of alcohol dependence.
Johnson, B. A. (2007) · PubMed Central · Cited by 42
Brain Opioid Receptor Binding of [3H]CTOP and [3H]Naltrindole in Alcohol-Preferring AA and Alcohol-Avoiding ANA Rats
Soini, S. L., Ovaska, T., Honkanen, A., Hyytiä, P., & Korpi, E. R. (1998) · Alcohol · doi:10.1016/s0741-8329(97)00125-0 · Cited by 42
Guidelines for Reasonable and Appropriate Care in the Emergency Department (GRACE‐4): Alcohol use disorder and cannabinoid hyperemesis syndrome management in the emergency department
Borgundvaag, B., Bellolio, F., Miles, I., Schwarz, E. S., Sharif, S., Su, M. K., Baumgartner, K. T., Liss, D. B., Sheikh, H., Vogel, J. A., et al. (2024) · Academic Emergency Medicine · doi:10.1111/acem.14911 · Cited by 42
Specific and Nonspecific Effects of Naltrexone on Goal-Directed and Habitual Models of Alcohol Seeking and Drinking
Hay, R. A., Jennings, J. H., Zitzman, D. L., Hodge, C. W., & Robinson, D. L. (2013) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.12081 · Cited by 41
Cravings as a mediator and moderator of drinking outcomes in the COMBINE study
Subbaraman, M. S., Lendle, S., van der Laan, M. J., Kaskutas, L. A., & Ahern, J. (2013) · Addiction · doi:10.1111/add.12238 · Cited by 41
Design, synthesis, and subtype selectivity of 3,6-disubstituted β-carbolines at Bz/GABA(A)ergic receptors. SAR and studies directed toward agents for treatment of alcohol abuse
Yin, W., Majumder, S., Clayton, T., Petrou, S., VanLinn, M. L., Namjoshi, O. A., Ma, C., Cromer, B. A., Roth, B. L., Platt, D. M., et al. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.08.049 · Cited by 41
A dysbiotic subpopulation of alcohol-dependent subjects
de Timary, P., Leclercq, S., Stärkel, P., & Delzenne, N. M. (2015) · Gut Microbes · doi:10.1080/19490976.2015.1107696 · Cited by 43
Emerging approaches to managing alcohol dependence
Swift, R. M. (2007) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp060644 · Cited by 41
Variable Dose Naltrexone‐Induced Hypothalamic‐Pituitary‐Adrenal Stimulation in Abstinent Alcoholics: A Preliminary Study
Farren, C. K., O’Malley, S. S., Grebski, G., Maniar, S., Porter, M., & Kreek, M. J. (1999) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1999.tb04144.x · Cited by 41
New Methodologies for Pharmacological Treatment Trials for Alcohol Dependence
Anton, R. F. (1996) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1996.tb01183.x · Cited by 41
Chemiluminescence determination of naltrexone based on potassium permanganate oxidation
Campiglio, A. (1998) · The Analyst · doi:10.1039/a706647c · Cited by 41
The Role of Biomarkers in Alcoholism Medication Trials
Allen, J. P., Litten, R. Z., Strid, N., & Sillanaukee, P. (2001) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2001.tb02325.x · Cited by 41
New therapies for alcohol problems: application to primary care
Fiellin, D. A., Reid, M. C., & O’Connor, P. G. (2000) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00448-9 · Cited by 42
Hypothalamic opioid–Melanocortin appetitive balance and addictive craving
Reece, A. S. (2010) · Medical Hypotheses · doi:10.1016/j.mehy.2010.09.002 · Cited by 40
Emerging drugs to treat alcoholism
Soyka, M., & Rösner, S. (2010) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2010.500811 · Cited by 42
Effects of systemic opioid receptor ligands on ethanol- and sucrose seeking and drinking in alcohol-preferring (P) and Long Evans rats
Henderson, A. N., & Czachowski, C. L. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3571-9 · Cited by 40
δ-Opioid Receptor Function in the Dorsal Striatum Plays a Role in High Levels of Ethanol Consumption in Rats
Nielsen, C. K., Simms, J. A., Li, R., Mill, D., Yi, H. Y., Feduccia, A. A., Santos, N., & Bartlett, S. E. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.5345-11.2012 · Cited by 40
Development of a mouse model of ethanol addiction: naltrexone efficacy in reducing consumption but not craving
Scheit, D. J. F., Ribeiro, A. F., Pigatto, G., Goeldner, F. O., & de Lacerda, R. B. (2006) · Journal of Neural Transmission · doi:10.1007/s00702-005-0416-z · Cited by 40
Cognitive behavioural therapy combined with the relapse-prevention medication acamprosate: are short-term treatment outcomes for alcohol dependence improved?
Feeney, G. F. X., Young, R. M., Connor, J. P., Tucker, J., & McPherson, A. (2002) · Australian & New Zealand Journal of Psychiatry · doi:10.1046/j.1440-1614.2002.01019.x · Cited by 40
The treatment of alcohol dependence
Assanangkornchai, S., & Srisurapanont, M. (2007) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e3280fa837d · Cited by 40
Involvement of the opioid system in the development and expression of sensitization to the locomotor-activating effect of ethanol
Camarini, R., Pires, M. L. N., & Calil, H. M. (2000) · The International Journal of Neuropsychopharmacology · doi:10.1017/s146114570000211x · Cited by 40
New pharmacological approaches for the treatment of alcoholism
Soyka, M., & Rösner, S. (2006) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.7.17.2341 · Cited by 40
Naltrexone and problems in pain management
Vickers, A. P., & Jolly, A. (2006) · BMJ · doi:10.1136/bmj.332.7534.132 · Cited by 40
Is behavioral tolerance learned?
Vogel-Sprott, M. D. (1997) · PubMed Central · Cited by 39
The Novel μ-Opioid Receptor Antagonist GSK1521498 Decreases Both Alcohol Seeking and Drinking: Evidence from a New Preclinical Model of Alcohol Seeking
Giuliano, C., Goodlett, C. R., Economidou, D., García-Pardo, M. P., Belin, D., Robbins, T. W., Bullmore, E. T., & Everitt, B. J. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.152 · Cited by 39
CLINICAL STUDY: Cloninger’s typology and treatment outcome in alcohol‐dependent subjects during pharmacotherapy with naltrexone
Kiefer, F., Jiménez‐Arriero, M. Á., Klein, O., Diehl, A., & Rubio, G. (2007) · Addiction Biology · doi:10.1111/j.1369-1600.2007.00073.x · Cited by 38

Authors: Volpicelli, J. R.
Affiliations: University of Pennsylvania (US)
Corresponding author: Volpicelli, Joseph R.
ORCID: Volpicelli, Joseph R.
Venue: Archives of General Psychiatry
Publisher: American Medical Association (AMA)
Published: 1992-11-01
Volume: 49
Issue: 11
Pages: 876
ISSN: 0003-990X (ISSN-L)
DOI: 10.1001/archpsyc.1992.01820110040006
OpenAlex: W2104538950
Cited by: 1,828
References: 23
Citations by year: 2026: 7 · 2025: 10 · 2024: 17 · 2023: 15 · 2022: 25 · 2021: 17 · 2020: 28 · 2019: 26 · 2018: 29 · 2017: 26 · 2016: 32 · 2015: 48 · 2014: 49 · 2013: 47 · 2012: 58
FWCI: 36.57
Type: journal article
Language: en
Open access: closed
Locations: Archives of General Psychiatry (publishedVersion)
PubMed (publishedVersion)
Funders: National Institute on Alcohol Abuse and Alcoholism (AA0751701A1)
National Institute on Drug Abuse (DA-05186)
Topics: Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
Health Sciences › Medicine › Clinical Neurology › Alcoholism and Thiamine Deficiency
Keywords: naltrexone, alcoholism, alcohol craving, alcohol relapse prevention, alcohol detoxification, outpatient care, opioid antagonists, adjunct pharmacotherapy, nausea, arthritic pain
MeSH terms: Adult, Alcohol Drinking, Alcoholism, Ambulatory Care, Combined Modality Therapy, Double-Blind Method, Humans, Male, Naltrexone, Nausea, Patient Dropouts, Placebos, Psychiatric Status Rating Scales, Psychotherapy, Recurrence, Severity of Illness Index, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Naltrexone in the Treatment of Alcohol Dependence

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks